chrisvoncsefalvay/vaers-outcomes huggingface dataset:
All of the joints in both arms ached/the joints in my left arm are sore; my left hip aches; As the evening progressed the throbbing pain spread across my pectorals, up to my chin, and all the way to my other arm; As the evening progressed the throbbing pain spread across my pectorals, up to my chin, and all the way to my other arm; As the evening progressed the throbbing pain spread across my pectorals, up to my chin, and all the way to my other arm; vaccine site started being sore; This is a spontaneous report from a contactable consumer/ Non-HCP (patient). This 52-year-old non-pregnant female consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not reported) via unknown route of administration, in the left arm, on 12Feb2021at 09:30 AM (age at the time of vaccination 52 years), at single dose for COVID-19 immunisation in the hospital. Patient's medical history included hypothyroidism, irritable bowel syndrome, primary hypertension, seasonal affective depression and flu. Patient had no known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not reported) via unknown route of administration, in left arm on 22Jan2021 at 09:30 AM (age at the time of vaccination 52 years), at single dose for COVID-19 immunisation in the hospital. The patient had no allergies with medications, food or other products. Concomitant medications in two weeks included levothyroxine sodium(thyroxine), sertraline, hyoscyamine and lisinopril. On 12Feb2021, the patient was a little sore that day, but not the next, vaccine site started being sore. On 14Feb2021 patient spent an hour shoveling snow in the morning, but wasn't sore afterwards. On 14Feb2021 (8 plus hours after shoveling snow), the vaccine site started being sore, but the pain was on again/off again. As the evening progressed the throbbing pain spread across my pectorals, up to my chin, and all the way to my other arm. All of the joints in both arms ached, 600 mg ibuprofen didn't seem to help. On 15Feb2021(Morning), the injection site is a little sore, the joints in her left arm are sore, and, weirdly, her left hip aches. The throbbing pain last night wasn't like any over-used muscle soreness I've ever experienced and the joint aching was also unlike anything I've experienced outside of when I've had the flu. Patient did not receive other vaccines within 4 weeks or prior vaccination. No COVID-19 prior the vaccination and no COVID-19 test was done post vaccination. Patient's treatment medication included ibuprofen. Outcome of the events were recovering.  Information on the lot/batch number has been requested.
I had a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (I had a sore arm) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (I had a sore arm). At the time of the report, PAIN IN EXTREMITY (I had a sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter Treatment information was not provided   This case was linked to MOD-2021-343894 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Follow up received on 08- Oct -2021 contains No New Information.
Experienced symptoms of Benign Paroxysimal Postural Vertigo or BPPD; Malaise; Felt like mild flu; Swelling; Joint Pain; Fatigue; Feeling feverish; A spontaneous report was received from a consumer concerning a 74-years-old, female patient who received Moderna's COVID-19 Vaccine, and who experienced joint pain, malaise, swelling, fatigue, felt like mild flu, feeling feverish and experienced symptoms of benign paroxysmal, postural vertigo or BPPD.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included Acetaminophen, Losartan, Hydrochlorothiazide, and Trazadone.  On 11 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number 026I20A) intramuscularly in the right arm deltoid for prophylaxis of COVID-19 infection.   On 14 Jan 2021, the patient experienced joint pain, malaise, swelling, fatigue, felt like mild flu, feeling feverish and experienced symptoms of benign paroxysimal, postural vertigo or BPPD.   Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events joint pain, malaise, swelling, fatigue, felt like mild flu, feeling feverish, and experienced symptoms of benign paroxysmal, postural vertigo or BPPD was not reported; Reporter's Comments: This spontaneous report concerns a 74-years-old, female patient who experienced joint pain, malaise, swelling, fatigue, felt like mild flu, feeling feverish and experienced symptoms of benign paroxysmal, postural vertigo or BPPD. The events occurred 3 days after the administration of the first dose of mRNA 1273 (lot number 026l20A, expiration date unknown).  No treatment information was provided, and outcome is Unknown.  Fever, fatigue and joint pain are consistent with the known safety profile of the mRNA-1273 vaccine and based on the current available information and temporal association between the use of the mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded.
Muscle aches and headache 12 hours post. Fever and chills 18 hours post that resolved with tylenol. Muscle aches, headache and fatigue 24 hours post.
On 1/31/01, parents reported fever and rash and temperature of 106.1F with red/pink, slightly raised rash on neck, head, abdomen and back. Seen by provider on 2/3/01 and child had extensive maculopapular rash on abdomen, chest and back. Physician's impression is viremia per blood culture done. Given Rocephin but results were no growth after 5 days.
Patient developed sore arm soreness 10/14/13. Then on 10/17/13 developed muscle pains in lower extremities with intermittent weak feeling. Progressed 10/21 to diffuse muscle pains over entire body. Then 10/25 also having chest tightness and shortness of breath. Was admitted to hospital 10/25 and had LP and MRI. Did not receive steroids or IVIG.
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual had received 3 doses of COVID-19 vaccine, having been vaccinated with the Moderna product on 02/19/2021, 03/19/2021, and 10/29/2021.   The individual became symptomatic for COVID-19 disease on 11/23/2021 and tested positive for COVID-19 twice on 11/28/2021.  The invidudual visited an Emergency Dept on 11/28/2021 and was admitted to hospital on the same day. They were transferred to a different hospital on 12/06/2021, where they remained until their death on 12/07/2021.
72 hrs p/2nd dose myalgia, severe h/a & mild c/o "nuchal rigidity", bilateral calf pain & weakness;
Received Tdap-IPV in left thigh. Within 24 hrs leg was swollen, red, painful - the size of a baseball 48 hrs later she was taken to emergency room and treated with KEFLEX for cellulitis with resolution of SX rapidly after antibiotics started. DX cellulitis.
Eczema; osteoporosis; hair loss; I have a cysts in my kidneys and liver; I have a cysts in my kidneys and liver; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number: Unknown) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced eczema, osteoporosis, and hair loss. I use special shampoo for my scalp. I have a cysts in my kidneys and liver on an unspecified date. Therapeutic measures were taken as a result of hair loss and included treatment with special shampoo. The outcome of the events was reported as unknown.
Hypotension 91/71 with orthostatic hypotension <80 SBP ( my BP cuff doesn?t read lower than that). Near syncope at 0615. Loss of vision, tinnitus, lowered to the ground and followed by nausea and sweating. Resolved in minutes. Continue to be dizzy today with clammy and dizzy upon standing
Received a Flu shot at the Pharmacy and then developed Influenza, reported same to the store and they just shrugged.
Burning chest and throat, headache, with flu symptoms. Deep cough, chills, hot/cold. No temperature. Overall sick feeling. Really bad on the 24-26th. Called DR on the 19th (?), received Promathazine-codeine syrup. Which helped. After syrup was gone,  on the 26th,  felt better on the 27th, but all the symptoms came back (except the headache) at night, to the morning of the 28th.  It has been 11 days and still feel like having a full blast of flue/cold. Heavy chest and coughing
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in left arm and on 25Apr2021 at 08:30 as dose 2, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Nov2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Managed anxiety" (unspecified if ongoing), notes: Managed anxiety. Concomitant medication(s) included: LEXAPRO, start date: 01Aug2018, stop date: 01Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. There were no known allergies. Completed Meds on 25May. Rebound symptoms Monday 29May-01Jun. Congestion returned. Headaches returned. Fatigue persistent throughout illness.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a IR Administrator of the clinic, and refers to a 12 months old infant patient of unknown gender. No medical history, concurrent condition and concomitant medications were reported. On 23-MAY-2016, the patient was vaccinated with improperly stored dose of VARIVAX lot # L048468 (strength, dosing details, anatomical location were unknown). All the VARIVAX vaccines with lot # L048468, were moved to the backup freezer on 15-APR-2016 and moved back at the end of AUG-2016. This is one of the several reports reported by the same reporter. Additional information has been requested.
High fever, 102.5. Headache, joint pain (specifically jaw and knees), lethargy, chills
The day after the injection I developed a bruise and tenderness at the site of the injection.  On 9/11  the pain had spread to the top of my shoulder to my elbow.  That area of my skin had become hard, red and splotchy and hot to the touch as well as itching.  I saw the doctor on 9/12 and was prescribed triamcinolone and was told to take Benadryl and allergy medication.  I noticed a little improvement by 9/13 and arm is still warm to the touch, itchy and swollen
I went the health clinic had 2 shot and waited for 15 mins. After waiting went home and was feeling ok. Later the same evening I had a elevated heart rate for several days. I followed up with my PCP and did test and lab work. It resolved on its own after a couple of days.
Vaccine administered at 1157. Patient reported symptoms at 1202 of dizziness, weakness, vision and hearing impairment. Initial blood pressure noted 84/42. Lead nurse made aware regarding  patient status. Repeat blood pressure 69/48 at 1202. Patient symptoms continue. Bp 98/55 at 1206. 1208 patient complaining of chest pressure.  1211 EMS notified regarding patient status. Patient continues dizzy and faint but remains responsive to verbal stimuli and responsive to name.  Awaiting EMS. At 1215 patient states he `feels better`.At 1223 EMS arrived and patient cleared at 1233. vs at 1239 BP 139/82, pulse 82, 99% oxygen,and 96.8 temp. 1242 medical director made aware and cleared for discharge. Awaiting patient family (father) to arrive for transfer home. At 1251 patient reports `chest pressure` and `indigestion`  VS 78/68 pulse 42 and 100% oxygen. At 1253 repeat VS 101/70 pulse 81. At 1255 patient continues to refuse transfer to hospital but states feeling better and symptoms have resolved. Father at patient side. At 1259 BP 112/77 pulse 51 and oxygen 99%. Patient escorted via wheelchair by lead nurse accompanied by father. Patient instructed to call 911 if symptoms return and verbalized understanding.
Initial report received on 17 March 2010 from a trial. This report was received from a phase II trial with investigational product MONOVALENT FLU A/H1N1 PRESERVATIVE or FLUZONE SV 2009-2010 or PLACEBO for which sanofi pasteur is not the sponsor. SAE Term: Hospitalized for Numbness in Right Leg. Onset Date: 19 February 2010. Causality: Not reported. Seriousness Criteria: Hospitalization/Prolonged Hospitalization. Documents held by sender: None.
A mother reported that her 3 year old daughter received injections of Prevnar, Infanrix, IPV and haemophilus influenzae type B conjugate vaccines on 10-DEC-2001 and 1 hour following immunization, developed diarrhea. Later that same evening, she developed fever of 104 degrees F and would not respond to her mother. She was hospitalized that evening and according to the pt's mother, "it was not determined what was wrong with her." As f 13-DEC-2001, her fever and diarrhea had resolved and she was discharged from the hospital. her mother reported that her daughter was "still not acting normal". As of the date of this report, no further information was available. Follow up info received 2/5/02 indicated that the pt reportedly developed fever of 104.7 deg F.
This spontaneous report as received from a nurse via a company representative refers to 30-40 patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) (0.5 ml, subcutaneously, lot # K013867 with expiration date 05-MAR-2016, lot # K005647 with expiration date 17-OCT-2016 and lot # K009197 with expiration date 27-DEC-2015). No adverse effects were reported. This is one of several reports from the same reporter. Additional information is not expected as the reporter did not grant permission to contact them or physician.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. The patient's current conditions or medical history were not reported. The nurse did not provide if the patients were previously vaccinated with M-M-R II (dose, route, lot numbers and expiration dates were not provided either). On an unknown date, the nurse reported that her region was having an outbreak of mumps. At the time of the report, outcome for outbreak of mumps was unknown. Additional information has been requested.
Symptoms began to appear Saturday afternoon- sore arm, slight headache and chills. By Saturday night included diarrhea. By Sunday morning slight fever, red face, dull eyes, very sore arm at injection site, muscle aches, bowel cramps and diarrhea. Today still have diarrhea, sore and now itchy left arm, muscle aches.
Bell?s Palsy Paralysis and swelling on the left side of the face  Prednisone for treatment
Inflammation and pain greater than expected. Tingling in arm from elbow down. Patient went to hospital and orthopedic doctor. The patient's sister says that the arm was too inflammed to do an MRI the day after receiving the vaccine and are going back to the orthopedic next week.
Swollen lymph node rt arm began same evening and continues fever 101F post 2 days body aches following day to 2 days chills following day fatigue following day to post 3 days
Fever, chills, fatigue, muscle and joint ache, headache, swollen lymph nodes under left arm, pain at injection site
generalized body pai, fever, chills, headache, neck stiffness, numbness in gingertips
Strong allergy symptoms. Heavy nose drainage and aching eyes/cheekbones. Lasted one day took Benadryl and slept.
This case was reported by a nurse via call center representative and described the occurrence of rash in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced rash after the first dose of SHINGRIX. No further details were available. The reporter did not give consent to follow up. The reporter declined to provide the patient identifiers and full demographics for herself. For tolerance to next dose, refer case US2019GSK058541.
2 hours after shot my ears blocked up and started ringing and hasn't stopped since. The blockage comes and goes but the ringing is constant.
After receiving his vaccine, patient had a slight syncopal episode.  Patient reported that he was going to get lightheaded as he normally gets this way with vaccines or blood draw. Patient never passed out; however, he almost fell when getting up from the vaccine chair, he reports lightheadedness and requested to lay down on the ground and have his feet elevated. Oxygen was brought to patient by post observation and 2 Liters delivered maintaining 99% saturation. After approximately six minutes, patient decided to get up from the ground. Two staff including patient?s wife assisted him to stand however, patient requested to be seated for a while. Patient was then moved to post observation where he was conscious, speaking clearly and monitored for an additional 30 minutes with no further incident.
EMS called patient had clinic tonic seizure lasting 30 seconds patient reports no seizure history. After seizure patient was alert and oriented x 4 Non labored breathing skin warm and dry.
5 days after Flu vaccine macular pink rash around the immunization site occurred. Rash was itchy but not painful. No induration. No respiratory SXS.
Extreme soreness, fever, chills, dry heaves, vomiting, almost passed out (did not), headache, body numb and paleness greater than 24 hours post vaccination.
Information has been received from an office staff member concerning a 14 year old male who on 15-JUL-2010 was vaccinated with the first dose of GARDASIL (lot# not reported). After received the vaccination, as he was sitting in the waiting room he felt like he was going to throw up and he was going to walk out the door. He fainted and hit his head on the banister and had to get stitches. Unspecified medical attention was sought. The outcome of the events was unknown. Follow up information has been received from physician concerning a patient with no medical history or drug reactions/allergies and no illness at the time of the vaccination, who on 15-JUL-2010 the first  dose of GARDASIL (Lot # 666121/1778Y), IM in the right arm at 14:00. Concomitant therapy included a first dose of MENACTRA (Lot # U3455AA) IM, into the left arm, given on the same day at 14:00. On 15-JUL-2010 at 14:15, the patient had a syncopal/fainting episode post immunization. The patient fell and hit his forehead on handrail requiring four superficial sutures at dermatologist. No further sequelae was reported. The patient recovered on 15-JUL-2010. There was no diagnostic laboratories studies performed. Additional information is not expected.
Information has been received from a licensed nurse practitioner referring to unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot # K025002, expiration date 20-JUL-2017, route and dose not provided). No adverse effects were reported. This is one of several reports received from the same source. This is one of several reports received from the same source. Additional information has been requested.
pt recvd vax; exp severe h/a; low fever; felt miserable; n at times; to MD on 3nov94; said several come in w/ flu like sxs w/ flu vax;
20 minutes of fever, chills, headache, fatigue, back ache. Repeated at 8:00 PM. Called out of work Saturday 1/9/2021
Rash, itching legs and arms. Patient states "he had a sea salt soak" for psoriasis the day after FLUZONE vac.
A couple days I developed a rash on my chest which looked like a scarlet fever and over the next few days it spreaded to my lower extremeties, back and stomach area and within a few days it disappeared on its on
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. No information about medical history, concurrent conditions was reported for the patient. On an unknown date the patient was vaccinated with improperly stored PROQUAD (Merck) (dose strength, route unspecified) lot # L003221, expiration date 30-JUL-2016. No adverse symptoms reported. The outcome of events reported was unknown. No product quality complaint was involved. This case is linked to the cases 1507USA008507, 1507USA008508 via same reporter link. Additional information has been requested.
Inhaled vaccine 12/12/2003 at 5:30pm. Patient threw up 4 hours later.  12/13 - cough and sore throat. 12/14 - runny nose and chest congestion. 12/15 - congestion and green phlegm coughed up 12/16- same as 12/15.  Out of school 12/14 and 12/15. He is tired.
Patient was given 2ml of Pfizer orange cap vaccine that was diluted with 1.0 ml of diluent instead of 1.3 ml of diluent
Pain in thigh area down to ankles, temp of 100.9, diarreah, pain and heaviness in chest area, took Advil.
Pt received shots walked to waiting room sat down, passed out. A different patient waiting for Radiology saw and helped him to the floor. Code blue was called.
no additional AE; an expired PNEUMOVAX23 was administered; Information has been received from a pharmacist referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On 14-JUL-2021, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 ml, lot# S024808, expiry date 02-JUN-2021; route of administration were not reported) for prophylaxis. The product had not experienced any temperature excursions. No additional adverse event involved. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S024808; expirationdate: 02-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability